Navigation Links
AVONEX in Medical News

First 10-year follow-up shows that treatment with AVONEX leads to long-term benefits in early multiple sclerosis patients

SEATTLE, WA April 30, 2009 Biogen Idec (NASDAQ: BIIB) today announced data results from the CHAMPIONS (Controlled High-Risk AVONEX (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an open label follow-up to CHAMPS (Controlled High Risk Subj...

First ten-year follow-up shows that treatment with AVONEX leads to long-term benefits in early multiple sclerosis patients

SEATTLE, WA April 30, 2009 Biogen Idec (NASDAQ: BIIB) today announced data results from the CHAMPIONS (Controlled High-Risk AVONEX (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an open label follow-up to CHAMPS (Controlled High Risk Subj...

New data show patients using avonex reported less sick leave and short-term disability costs

Denver, CO June 2, 2008 Results from an analysis assessing the differences in health benefits costs (HBCs) and lost time among employees suffering from multiple sclerosis (MS) being treated with injectable disease modifying therapies (DMTs) were presented and announced by Biogen Idec as poster p...

MS Patients More Compliant with Medications When Managed by Specialty Pharmacy, According to HealthCore Study Presented at ISPOR

... with 79 percent managed and 21 percent non-managed. The median age was 46 years and the majority was female. More than one-third of the patients used avonex as index medication, while others used Copaxone (31 percent), Rebif (17 percent), Betaseron (14 percent) and Tysabri (less than 1 percent). Abou...

Study shows that high-dose, high-frequency interferon produces no additional benefit

...V, open label, head-to-head study of intramuscular avonex and high-dose, high-frequency subcutaneous Rebif (...and Retrospective Long-Term Observational Study of avonex and Rebif (PROOF), involved 217 patients with 136 completing a median of 25.9 months of avonex 30 mcg once weekly (n=69) and a median of 22.2 mon...

New Data Suggests Progression of Disability at Two Years Predicts Multiple Sclerosis (MS) Disability Progression at Eight Years

...(RRMS). The analysis suggests that patients taking avonex for two years were less likely to experience disab...atment (81 placebo, 79 interferon beta-1a), in the avonex Phase III trial and who were re-examined eight yea...ysis revealed: -- Patients initially treated with avonex were less likely than patients initially recei...

Multiple Sclerosis Patients to Benefit With AVONEX(R) Nurse Services Program

...," said Marie Stallbaum, RN, BSN, a nurse with the avonex Nurse Services Program. "Nurses in this program wi...fullest and most active lives possible." The avonex Nurse Services program will have registered nurses...side effects ?Valuable phone counseling "The avonex Nurse Services program is the latest example of ou...
AVONEX in Medical Technology

New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective Relative to Other Interferon Therapies for Multiple Sclerosis

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 13, 2007 - Biogen Idec Inc. (NASDAQ: BIIB) announced today that one-year data presented at the Academy of Managed Care Pharmacy's (AMCP) 2007 Annual Meeting show that AVONEX(R) (Interferon beta-1a) is a cost-effective therapy in multiple sclerosis (MS) when co...

Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line

...patients. "Surveyed neurologists' responses suggest that Biogen Idec's avonex is more at-risk than Teva's Copaxone of losing share upon the launch of either oral cladribine or fingolimod, as more physicians cite avonex as having potential for being replaced by either emerging oral agent," stat...
AVONEX in Biological Technology

Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning

...e Officer of Tengion. "Mark brings extensive experience and a proven track record in both large pharma and biotech, including the successful launch of avonex for multiple sclerosis. His broad expertise in managing commercial activities across all stages of product development, and in specialty markets, will...

Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis

...est in first-line therapy. "The low volume of patient share attributed to avonex or Rebif compared with Copaxone in first- and second-line treatment illustr...h-dose, high-frequency agent reaches patient shares close to and surpassing avonex in first- and second-line treatment, respectively." According to the new ...

Olympics of biotechnology has international flavor

...cer. 1991 : Genzyme's Ceredase is approved by the FDA to treat Gaucher's disease and had 2006 sales of over $1 billion. 1996 : Biogen's drug avonex for multiple schlerosis is approved by the FDA, also with sales of over $1 billion annually. 2003 : The Broad Institute founded in Cambridge to g...
Other Tags
(Date:3/4/2015)... Cook For Your Life (CFYL), a New ... to people touched by cancer, is launching its first ... by founder Ann Ogden, will be facilitated by Drexel ... partnership will expand the program from its base. , ... After going through her own cancer treatments, Ogden realized ...
(Date:3/4/2015)... growing influence of movies, television, video games and the internet ... with the increasingly frantic lifestyle of modern parents, it can ... what kids are into these days. It seems that every ... , The same is also true for drugs and alcohol. ... talk about them, are constantly changing. These tips put a ...
(Date:3/4/2015)... Surrey, BC (PRWEB) March 04, 2015 ... will perform LASIK and PRK procedures at their new ... Vision Correction, Dr. Joseph King and Dr. Gabriel Chu ... ophthalmology practice in Surrey is named Fraser Valley Cataract ... facility is accredited by the College of Physicians and ...
(Date:3/4/2015)... NY (PRWEB) March 04, 2015 The ... centerfold of The San Francisco Chronicle with a circulation ... 500,000 readers. Its digital component is distributed nationally through ... of top news sites and partner outlets. To explore ... , Milorganite is composed of heat-dried microbes ...
(Date:3/4/2015)... Texas (PRWEB) March 04, 2015 ... , Endometriosis can be a painful condition ... starts spreading outside of the uterus leading to very ... their families. Endometriosis can have a terrible effect on ... It is also the most common cause of infertility ...
Breaking Medicine News(10 mins):Health News:Drexel University and Cook for Your Life Team Up 2Health News:Drexel University and Cook for Your Life Team Up 3Health News:Drexel University and Cook for Your Life Team Up 4Health News:Drexel University and Cook for Your Life Team Up 5Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:King LASIK relocates to Surrey, British Columbia 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3
(Date:3/4/2015)... , Mar. 04, 2015 Research and Markets ... addition of the "Global Biometrics Market Forecast ... The market for biometric authentication systems ... around 14% till 2020 The driving ... increasing security needs, government projects and constant development ...
(Date:3/3/2015)... FOREST, Calif. , March 3, 2015 ... the leading provider of advanced cryogenic logistics ... markets including immunotherapies, stem cells, cell lines, ... and reproductive medicine, today announced the expansion ... Cancer Research Centers, ("Fred Hutch") Clinical ...
(Date:3/2/2015)... 2, 2015 Synaptics Inc. (NASDAQ: ... interface solutions, today announced a new implementation of ... enable rapid and secure transactions and reliable identification ... is a turnkey solution providing mouse and keyboard ... integrate fingerprint ID solutions into their product offerings, ...
Breaking Biology News(10 mins):Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3
Other Contents